aod9604 clinical trial obesity results AOD 9604: Peptide Claims vs Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side Mg:10 mg 5-Amino-1MQ — Research Peptide NAD

aod9604 clinical trial obesity results AOD 9604: Peptide Claims vs Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side Mg:10 mg 5-Amino-1MQ — Research Peptide NAD

5-Amino-1MQ — Research Peptide | AminoStock

10.1074/jbc.M601284200 [DOI] [PubMed] [Google Scholar] Kanazawa A., Tsukada S., Kamiyama M., Yanagimoto T., Nakajima M., Maeda S

NAD

Mg:10 mg

No thyroid C-cell tumors were observed in human trial participants, though this risk carries a theoretical basis from rodent studies and is listed as a precaution, as it is with all GLP-1 class compounds